StockWatch
·
Biotechnology
Quarterly Result31 Oct 2026, 03:50 pm

Advanced Enzyme Q2 FY27 Revenue Up 16% to ₹2,145 Mn

AI Summary

Advanced Enzyme Technologies Limited announced its unaudited financial results for the second quarter and half year ended September 2026. Consolidated revenue from operations increased by 16% year-on-year to ₹2,145 million in Q2 FY27 from ₹1,845 million in Q2 FY26. EBITDA grew by 20% to ₹721 million, and Profit After Tax (PAT) rose by 14% to ₹512 million. The company reported strong growth in its Animal Nutrition (37% YoY) and Bio-Processing (43% YoY) segments. Domestic sales constituted 52% of revenue, an increase from 48% in the prior year quarter.

Key Highlights

  • Q2 FY27 consolidated revenue grew 16% YoY to ₹2,145 million.
  • EBITDA increased 20% YoY to ₹721 million.
  • PAT rose 14% YoY to ₹512 million.
  • Animal Nutrition and Bio-Processing segments showed significant growth.
  • Domestic sales share increased to 52% of total revenue.